Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:15 PM View:  | Shaff Eric D. CEO and President Director | Seres Therapeutics, Inc. (MCRB) | 18-Nov-24 | Planned Option Sale | 2,505 | $0.54 | $1,354.95 | (1%) 172.89K to 170.39K | |
| 19-Nov-24 4:15 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 18-Nov-24 | Planned Option Sale | 735 | $0.54 | $397.64 | (< 1%) 91.14K to 90.4K | |
| 19-Nov-24 4:15 PM View: | Henn Matthew R. See Remarks | Seres Therapeutics, Inc. (MCRB) | 18-Nov-24 | Planned Option Sale | 927 | $0.54 | $501.23 | (1%) 78.7K to 77.77K | |
| 19-Nov-24 4:20 PM View: | von Moltke Lisa See Remarks | Seres Therapeutics, Inc. (MCRB) | 18-Nov-24 | Planned Option Sale | 977 | $0.54 | $528.26 | (3%) 33.39K to 32.41K | |
| 19-Nov-24 4:15 PM View: | Henn Matthew R. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-Nov-24 | Option Exercise | 2,812 | -- | -- | 4% 75.89K to 78.7K | |
| 19-Nov-24 4:20 PM View: | von Moltke Lisa See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-Nov-24 | Option Exercise | 2,969 | -- | -- | 10% 30.42K to 33.39K | |
| 19-Nov-24 4:15 PM View: | Shaff Eric D. CEO and President Director | Seres Therapeutics, Inc. (MCRB) | 15-Nov-24 | Option Exercise | 7,812 | -- | -- | 5% 165.08K to 172.89K | |
| 19-Nov-24 4:15 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-Nov-24 | Option Exercise | 2,656 | -- | -- | 3% 88.48K to 91.14K | |
| 19-Aug-24 5:36 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 16-Aug-24 | Planned Option Sale | 728 | $0.84 | $611.52 | (< 1%) 80.83K to 80.11K | |
| 19-Aug-24 5:29 PM View: | Ege David S. See Remarks | Seres Therapeutics, Inc. (MCRB) | 16-Aug-24 | Planned Option Sale | 1,128 | $0.84 | $947.52 | (1%) 78.7K to 77.58K | |
| 19-Aug-24 5:36 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-Aug-24 | Option Exercise | 2,656 | -- | -- | 3% 78.18K to 80.83K | |
| 19-Aug-24 5:29 PM View: | Ege David S. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-Aug-24 | Option Exercise | 2,969 | -- | -- | 4% 75.73K to 78.7K | |
| 06-Aug-24 4:15 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 05-Aug-24 | Planned Option Sale | 24,480 | $1.08 | $26,533.90 | (24%) 102.66K to 78.18K | |
| 06-Aug-24 4:15 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 03-Aug-24 | Option Exercise | 85,000 | -- | -- | 481% 17.66K to 102.66K | |
| 17-May-24 8:23 PM View: | von Moltke Lisa See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Planned Option Sale | 939 | $0.94 | $882.66 | (5%) 19.96K to 19.02K | |
| 17-May-24 8:14 PM View: | Desrosier Thomas Chief Legal Officer and EVP | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Option Exercise | 2,656 | -- | -- | 2% 120.58K to 123.23K | |
| 17-May-24 8:18 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Planned Option Sale | 703 | $0.94 | $660.82 | (4%) 18.36K to 17.66K | |
| 17-May-24 8:18 PM View: | Shaff Eric D. CEO and President Director | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Planned Option Sale | 2,435 | $0.94 | $2,288.90 | (2%) 143.13K to 140.7K | |
| 17-May-24 8:17 PM View: | Henn Matthew R. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Option Exercise | 2,812 | -- | -- | 4% 63.44K to 66.25K | |
| 17-May-24 8:16 PM View: | Ege David S. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Option Exercise | 2,968 | -- | -- | 4% 73.86K to 76.82K | |
| 17-May-24 8:14 PM View: | Desrosier Thomas Chief Legal Officer and EVP | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Planned Option Sale | 843 | $0.94 | $792.42 | (< 1%) 123.23K to 122.39K | |
| 17-May-24 8:18 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Option Exercise | 2,656 | -- | -- | 17% 15.71K to 18.36K | |
| 17-May-24 8:17 PM View: | Henn Matthew R. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Planned Option Sale | 891 | $0.94 | $837.54 | (1%) 66.25K to 65.36K | |
| 17-May-24 8:16 PM View: | Ege David S. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Planned Option Sale | 1,090 | $0.94 | $1,024.60 | (1%) 76.82K to 75.73K | |
| 17-May-24 8:23 PM View: | von Moltke Lisa See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Option Exercise | 2,968 | -- | -- | 17% 16.99K to 19.96K | |
| 17-May-24 8:18 PM View: | Shaff Eric D. CEO and President Director | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Option Exercise | 7,812 | -- | -- | 6% 135.32K to 143.13K | |
| 16-Feb-24 9:31 PM View: | Henn Matthew R. See Remarks | Seres Therapeutics, Inc. (MCRB) | 16-Feb-24 | Planned Option Sale | 4,170 | $1.08 | $4,503.60 | (6%) 67.61K to 63.44K | |
| 16-Feb-24 9:15 PM View: | Ege David S. See Remarks | Seres Therapeutics, Inc. (MCRB) | 16-Feb-24 | Planned Option Sale | 5,010 | $1.08 | $5,410.80 | (6%) 78.87K to 73.86K | |
| 16-Feb-24 9:29 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 16-Feb-24 | Planned Option Sale | 3,374 | $1.08 | $3,643.92 | (18%) 19.08K to 15.71K | |
| 16-Feb-24 9:13 PM View: | Arkowitz David Chief Financial Officer | Seres Therapeutics, Inc. (MCRB) | 16-Feb-24 | Planned Option Sale | 3,939 | $1.08 | $4,254.12 | (2%) 186.38K to 182.44K | |
| 16-Feb-24 9:21 PM View: | von Moltke Lisa See Remarks | Seres Therapeutics, Inc. (MCRB) | 16-Feb-24 | Planned Option Sale | 4,400 | $1.08 | $4,752.00 | (21%) 21.39K to 16.99K | |
| 16-Feb-24 9:42 PM View: | Shaff Eric D. CEO and President Director | Seres Therapeutics, Inc. (MCRB) | 16-Feb-24 | Planned Option Sale | 11,549 | $1.08 | $12,472.90 | (8%) 146.87K to 135.32K | |
| 16-Feb-24 9:48 PM View: | Desrosier Thomas Chief Legal Officer and EVP | Seres Therapeutics, Inc. (MCRB) | 16-Feb-24 | Planned Option Sale | 3,939 | $1.08 | $4,254.12 | (3%) 124.52K to 120.58K | |
| 16-Feb-24 9:13 PM View: | Arkowitz David Chief Financial Officer | Seres Therapeutics, Inc. (MCRB) | 15-Feb-24 | Option Exercise | 10,625 | -- | -- | 6% 175.76K to 186.38K | |
| 16-Feb-24 9:21 PM View: | von Moltke Lisa See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-Feb-24 | Option Exercise | 11,875 | -- | -- | 125% 9.51K to 21.39K | |
| 16-Feb-24 9:42 PM View: | Shaff Eric D. CEO and President Director | Seres Therapeutics, Inc. (MCRB) | 15-Feb-24 | Option Exercise | 31,250 | -- | -- | 27% 115.62K to 146.87K | |
| 16-Feb-24 9:48 PM View: | Desrosier Thomas Chief Legal Officer and EVP | Seres Therapeutics, Inc. (MCRB) | 15-Feb-24 | Option Exercise | 10,625 | -- | -- | 9% 113.89K to 124.52K | |
| 16-Feb-24 9:31 PM View: | Henn Matthew R. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-Feb-24 | Option Exercise | 11,250 | -- | -- | 20% 56.36K to 67.61K | |
| 16-Feb-24 9:15 PM View: | Ege David S. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-Feb-24 | Option Exercise | 11,875 | -- | -- | 18% 66.99K to 78.87K | |
| 16-Feb-24 9:29 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 15-Feb-24 | Option Exercise | 10,625 | -- | -- | 126% 8.45K to 19.08K | |
| 31-Oct-23 9:39 PM View: | Desrosier Thomas Chief Legal Officer and EVP | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 4,156 | $1.35 | $5,610.60 | (4%) 118.05K to 113.89K | |
| 31-Oct-23 9:36 PM View: | Henn Matthew R. See Remarks | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 3,886 | $1.35 | $5,246.10 | (6%) 60.24K to 56.36K | |
| 31-Oct-23 9:39 PM View: | Ege David S. See Remarks | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 4,066 | $1.35 | $5,489.10 | (6%) 71.06K to 66.99K | |
| 31-Oct-23 9:43 PM View: | Cloghessy Paula See Remarks | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 2,904 | $1.35 | $3,920.40 | (6%) 48.59K to 45.68K | |
| 31-Oct-23 9:40 PM View: | Young Teresa L. See Remarks | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 2,907 | $1.35 | $3,924.45 | (26%) 11.36K to 8.45K | |
| 31-Oct-23 9:39 PM View: | Arkowitz David Chief Financial Officer | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 4,066 | $1.35 | $5,489.10 | (2%) 179.82K to 175.76K | |
| 31-Oct-23 9:36 PM View: | von Moltke Lisa See Remarks | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 4,232 | $1.35 | $5,713.20 | (31%) 13.74K to 9.51K | |
| 31-Oct-23 9:40 PM View: | Shaff Eric D. CEO and President Director | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 8,552 | $1.35 | $11,545.20 | (7%) 124.17K to 115.62K | |
| 31-Oct-23 9:36 PM View: | Henn Matthew R. See Remarks | Seres Therapeutics, Inc. (MCRB) | 27-Oct-23 | Option Exercise | 12,623 | -- | -- | 27% 47.62K to 60.24K | |
| 31-Oct-23 9:43 PM View: | Cloghessy Paula See Remarks | Seres Therapeutics, Inc. (MCRB) | 27-Oct-23 | Option Exercise | 9,418 | -- | -- | 24% 39.17K to 48.59K |
